Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EUROPE

Denmark

France

Germany

Hungary

Ireland

Italy

Netherlands

Poland

Portugal

Romania

Spain

Sweden

United Kingdom

EMEA (REGIONAL)

Egypt

South Africa

Tunisia

Turkey

Ukraine

ASIA PACIFIC

Asia Pacific (Regional)

China

India

Indonesia

Japan

Korea

Malaysia

Philippines

Florkem box and bottle
Florkem box
Florkem bottle
Florkem box and bottle
Florkem box
Florkem bottle

Florkem

Florfenicol injectable with a high syringeability1and in the hi-tech CLAS vial. Indicated for the treatment of respiratory tract infections in cattle due to Mannheimia haemolyticaPasteurella multocida and Histophilus somni susceptible to florfenicol.

Available in:

  • 100 mL
  • 250 mL

Target species:

  • cattle icon Cattle
  • pig icon Swine

Product information

How to use

Use in cattle

  • Respiratory Tract Infections: 1ml/15kg, twice 48 hours apart, IM
  • Withdrawal (meat and offal) 37 days

Use in pigs

  • Swine Respiratory Disease: 1ml/20kg, twice 48 hours apart, IM
  • Withdrawal (meat and offal) 18 days

Please refer to the product packaging and leaflets for information about specific indications for use, side effects, precautions, warnings and contra-indications. Further information is available from the SPC or on the datasheet or on request.

Legal Category: IE POM

Neonatal calf and cow. Reproduction.

Why choose
Florkem?

High syringeability

Florkem formulation was designed for a high syringeability. It is easy to inject, even at low temperatures, reducing the chance of dosing errors and possible muscle trauma1

Broad spectrum

High susceptibility of most frequent bacteria associated with bronchopneumonia

Fast acting

Therapeutic concentrations in florfenicol are reached within 30 minutes in blood and less than 2 hours in lungs after injection2

Marked reduction in rectal temperature observed within 24 hours3

Hi-tech CLAS vial

In a shock-resistant vial, resulting in fewer
breakages if dropped4

Ergonomically designed5 and are light-weight for ease of handling6

Supports the responsible use of antibiotics

Not used for the treatment of humans and not classified as a critically important antibiotic7,8

Recent European data reported no change in the very high susceptibility in target pathogens9

References

1. Manteca C, Lacoste S, Riboud C, Remmy D (2011) Comparison of injectability of 4 different formulations of florfenicol. European Buiatrics Forum, Marseille. 189. 2. Varma KJ (1994) Microbiology, pharmacokinet ...

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.